CytoDyn Inc.
看多

Cytodyn due for a pop into October

347
CYDY performance has been dismal since the out-of-protocol "hold your horses!" FDA letter in late May, continuing down in a withering C wave. A great article posted by our friends KenChowder and ohm on Democrat blog dailykos.com yesterday was angrily removed by complainers conditioned to treat any good news on therapeutics as crazy Trumpist propaganda from the horse dewormer crowd. None of the great results coming in on cancer or NASH or COVID in Philippines is priced in. I think we've wallowed in bad news long enough and this week will have marked a slow rounded bottom at $1.23 with a pop to test the $2.75 apex of the purple wedge in October BEFORE the shareholder meeting and 13D standoff completes.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。